We use press releases to update external stakeholders on our progress. We want to make sure you have all the information you need to provide comprehensive feedback on our reports.
Subscribers can expect to receive press releases at the following milestones: Topic Announcement, Draft Evidence Report, Revised Evidence Report, and Final Evidence Report.
You can also find the week’s press releases in our newsletter.
For any questions, please contact mediainquiries@icer.org.
Sign up for our Press Releases and Newsletter!
Featured Press Releases
ICER Publishes Final Evidence Report and Policy Recommendations on Therapies for Lupus Nephritis
— For belimumab and voclosporin, independent appraisal committee votes highlight the importance of several potential benefits of both treatments for patients and families beyond health improvement. —
04/16/2021ICER to Use Aetion Observational RWE to Update Value Assessment of Treatments for Hereditary Angioedema
New ICER pilot will incorporate more than 24 months of observational real-world demographic, utilization, and cost data to further clarify therapies’ value. Through continued use of the Aetion Evidence Platform, ICER advances the use of transparent, replicable real-world evidence in health technology assessment.
04/12/2021ICER Analytics™ Launched to Accelerate the Real-World Application of ICER Reports, Helping Payers, the Life Science Industry, and Health Care Policy Makers Move From Insight to Action
ICER formally launched ICER Analytics™, a new cloud-based platform that will revolutionize the ability of payers, life science companies, patient groups, and others to develop formularies, negotiate drug prices.
11/30/2020